X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (128) 128
cutaneous leishmaniasis (108) 108
animals (102) 102
index medicus (99) 99
leishmaniasis, cutaneous - drug therapy (90) 90
topical treatment (83) 83
administration, topical (80) 80
female (72) 72
paromomycin (66) 66
male (58) 58
leishmaniasis (49) 49
mice (49) 49
antiprotozoal agents - therapeutic use (48) 48
pharmacology & pharmacy (48) 48
paromomycin - therapeutic use (45) 45
paromomycin - administration & dosage (43) 43
antiprotozoal agents - administration & dosage (42) 42
visceral leishmaniasis (42) 42
dermatology (41) 41
leishmaniasis, cutaneous - parasitology (38) 38
mice, inbred balb c (38) 38
parasitic diseases (38) 38
adult (35) 35
tropical medicine (34) 34
leishmaniasis, cutaneous (33) 33
middle aged (33) 33
parasitology (33) 33
topical paromomycin (32) 32
treatment outcome (32) 32
meglumine antimoniate (31) 31
double-blind (30) 30
adolescent (29) 29
sodium stibogluconate (29) 29
care and treatment (25) 25
child (25) 25
child, preschool (25) 25
infectious diseases (25) 25
microbiology (24) 24
ointment (23) 23
efficacy (22) 22
in-vitro (22) 22
ointments (22) 22
skin (22) 22
leishmaniasis - drug therapy (21) 21
health aspects (20) 20
drugs (19) 19
leishmania major (19) 19
methylbenzethonium chloride (19) 19
antiprotozoal agents - pharmacology (18) 18
benzethonium - analogs & derivatives (18) 18
chemotherapy (18) 18
leishmaniasis, cutaneous - therapy (18) 18
aminosidine (17) 17
drug therapy, combination (17) 17
intralesional meglumine antimoniate (17) 17
leishmania - drug effects (17) 17
administration, cutaneous (16) 16
aged (16) 16
drug delivery systems (16) 16
phosphorylcholine - analogs & derivatives (16) 16
placebo-controlled trial (16) 16
public, environmental & occupational health (16) 16
amphotericin b (15) 15
analysis (15) 15
immunology (15) 15
infection (15) 15
liposomes (15) 15
research article (15) 15
benzethonium - therapeutic use (14) 14
disease models, animal (14) 14
leishmania (14) 14
leishmaniasis, cutaneous - diagnosis (14) 14
leishmaniasis, cutaneous - pathology (14) 14
liposomal amphotericin-b (14) 14
miltefosine (14) 14
paromomycin - pharmacology (14) 14
randomized clinical-trial (14) 14
therapy (14) 14
world cutaneous leishmaniasis (14) 14
administration, oral (13) 13
antiprotozoal agents - adverse effects (13) 13
clinical trials (13) 13
leishmania major - drug effects (13) 13
leishmania tropica (13) 13
parasites (13) 13
paromomycin - adverse effects (13) 13
skin absorption (13) 13
amphotericin-b (12) 12
drug resistance (12) 12
lesions (12) 12
research (12) 12
antileishmanial activity (11) 11
cryotherapy (11) 11
drug therapy (11) 11
formulations (11) 11
mucosal leishmaniasis (11) 11
sodium stibogluconate pentostam (11) 11
time factors (11) 11
young adult (11) 11
aminoglycosides (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2013, Volume 368, Issue 6, pp. 524 - 532
Journal Article
Contact Dermatitis, ISSN 0105-1873, 11/2019, Volume 81, Issue 5, pp. 393 - 394
Paromomycin, previously named aminosidine, is an aminoglycoside that was isolated in the 1950s from Streptomyces krestomuceticus. Its spectrum of activity... 
case report | kanamycin | paromomycin | allergic contact dermatitis | cutaneous leishmaniasis | neomycin | EFFICACY | TOPICAL TREATMENT | CROSS-SENSITIVITY | METHYLBENZETHONIUM CHLORIDE | DERMATOLOGY | ALLERGY | SENSITIZATION | WORLD CUTANEOUS LEISHMANIASIS | OINTMENT | Allergic contact dermatitis | Neomycin | Leishmaniasis | Contact dermatitis | Paromomycin
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 05/2019, Volume 13, Issue 5, p. e0007253
Paromomycin-based topical treatments were shown to be effective in curing cutaneous leishmaniasis (CL) lesions caused by Leishmania major in Tunisia. Cure... 
Aminoglycosides | Meglumine antimoniate | Leishmaniasis, Cutaneous | Vector-borne diseases | Medical research | Gentamicin | Cream | Bioethics | Leishmaniasis | Pruritus | Dermatitis | Cutaneous leishmaniasis | Pain | Parasitic diseases | Topical application | Lesions | Paromomycin
Journal Article
Journal of Dermatological Science, ISSN 0923-1811, 10/2018, Volume 92, Issue 1, pp. 78 - 88
Cutaneous leishmaniasis (CL) skin lesions are the result of a deregulated immune response, which is unable to eliminate parasites. The control of both,... 
Cutaneous leishmaniasis | Topical therapy | Anti-TNFα antibodies | Macrophages | Paromomycin | ACTIVATION | INDUCTION | DERMATOLOGY | PATHOGENESIS | IN-VITRO | NITRIC-OXIDE | INFANTUM | Anti-TNF alpha antibodies | OF-THE-LITERATURE | RECEPTORS | VISCERAL LEISHMANIASIS | Tumor Necrosis Factor-alpha - metabolism | Leishmania major - immunology | Dermatitis - immunology | Imiquimod | Skin - metabolism | Leishmaniasis, Cutaneous - immunology | Macrophages - parasitology | Paromomycin - pharmacology | Inflammation Mediators - metabolism | Tumor Necrosis Factor-alpha - immunology | Leishmania major - pathogenicity | Female | Inflammation Mediators - antagonists & inhibitors | Drug Therapy, Combination | Macrophages - immunology | Neutrophil Infiltration - drug effects | Disease Models, Animal | Skin - immunology | Inflammation Mediators - immunology | Leishmania major - drug effects | Cells, Cultured | Skin - parasitology | Leishmaniasis, Cutaneous - drug therapy | Leishmaniasis, Cutaneous - metabolism | Antiprotozoal Agents - pharmacology | Antibodies - pharmacology | Host-Pathogen Interactions | Dermatitis - etiology | Macrophages - metabolism | Animals | Leishmaniasis, Cutaneous - parasitology | Macrophages - drug effects | Mice, Inbred BALB C | Skin - drug effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Dermatitis - drug therapy | Dermatitis - metabolism
Journal Article
Journal Article
Pharmaceutical Development and Technology, ISSN 1083-7450, 03/2019, Volume 24, Issue 3, pp. 390 - 393
Ex vivo evaluation of drug release and skin permeation from topical formulations of antileishmanial drug paromomycin sulphate was carried out using intact full... 
topical emulgel | Paromomycin permeation | cutaneous leishmaniasis | human skin | potency-based microbiological assay | TOPICAL TREATMENT | PHARMACOLOGY & PHARMACY
Journal Article
Clinical & Experimental Dermatology, ISSN 0307-6938, 09/2006, Volume 31, Issue 5, pp. 634 - 637
Summary Background.  The optimal treatment for cutaneous leishmaniasis (CL) is not known. Topical paromomycin is one of the many drugs that have been suggested... 
5-AMINOLEVULINIC ACID | DOUBLE-BLIND | SKIN | DERMATOLOGY | Photosensitizing Agents - therapeutic use | Paromomycin - therapeutic use | Humans | Middle Aged | Child, Preschool | Male | Leishmaniasis, Cutaneous - drug therapy | Photochemotherapy | Amebicides - therapeutic use | Adolescent | Adult | Female | Administration, Topical | Child | Clinical trials
Journal Article
Journal Article